Roivant Sciences Ltd (ROIV)

Roivant Sciences Ltd (ROIV) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $27.1B; returns 1 day -2.6%, 1 week +8.8%, 1 year +101.4%.

Roivant Sciences Ltd (ROIV) is a biopharmaceutical company that develops and commercializes medicines through a unique model of creating and incubating subsidiary 'Vants' focused on specific therapeutic areas, while retaining stakes in their assets.

Groups ROIV belongs to

• Healthcare
• Biotechnology
• Biopharmaceutical
• United Kingdom Companies
• Life Sciences
• Immunotherapy
• Autoimmune Diseases
• Dermatology
• Rare Diseases
• Commercial Stage Biotech

ROIV financial model: income statement, cash flow and balance sheet